PODCAST · health
On The Pen With Man On The Mounjaro: Dave Knapp
by Dave Knapp
Welcome to the On The Pen: GLP-1 News Podcast, your go-to source for the latest updates on all things GLP-1 and incretin mimetic treatments. In this podcast, we bring you breaking news, in-depth analysis, and insights on all things GLP-1. Tirzepatide, also known as Mounjaro, is a novel GLP-1 receptor agonist developed by Eli Lilly. It has shown exciting results in clinical trials for obesity treatment, and is FDA approved for the treatment of Type 2 Diabetes. In each episode, we cover the latest breaking developments in pharma's incretin research and development, including updates on clinical trials, regulatory approvals, and market trends. We also feature interviews with leading experts in the field, as well as those who are using these treatments in the real world. Our podcast is designed for users of incretin and GLP-1 medications (specifically Mounjaro), and anyone interested in the latest developments in diabetes and obesity treatment. Whether you're looking for the latest n
No episodes available yet.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Welcome to the On The Pen: GLP-1 News Podcast, your go-to source for the latest updates on all things GLP-1 and incretin mimetic treatments. In this podcast, we bring you breaking news, in-depth analysis, and insights on all things GLP-1. Tirzepatide, also known as Mounjaro, is a novel GLP-1 receptor agonist developed by Eli Lilly. It has shown exciting results in clinical trials for obesity treatment, and is FDA approved for the treatment of Type 2 Diabetes. In each episode, we cover the latest breaking developments in pharma's incretin research and development, including updates on clinical trials, regulatory approvals, and market trends. We also feature interviews with leading experts in the field, as well as those who are using these treatments in the real world. Our podcast is designed for users of incretin and GLP-1 medications (specifically Mounjaro), and anyone interested in the latest developments in diabetes and obesity treatment. Whether you're looking for the latest n
HOSTED BY
Dave Knapp
Loading similar podcasts...
Frequently Asked Questions
How many episodes does On The Pen With Man On The Mounjaro: Dave Knapp have?
On The Pen With Man On The Mounjaro: Dave Knapp currently has 0 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is On The Pen With Man On The Mounjaro: Dave Knapp about?
Welcome to the On The Pen: GLP-1 News Podcast, your go-to source for the latest updates on all things GLP-1 and incretin mimetic treatments. In this podcast, we bring you breaking news, in-depth analysis, and insights on all things GLP-1. Tirzepatide, also known as Mounjaro, is a novel GLP-1...
How often does On The Pen With Man On The Mounjaro: Dave Knapp release new episodes?
On The Pen With Man On The Mounjaro: Dave Knapp is no longer actively publishing new episodes, but the existing catalog remains available.
Where can I listen to On The Pen With Man On The Mounjaro: Dave Knapp?
You can listen to On The Pen With Man On The Mounjaro: Dave Knapp on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts On The Pen With Man On The Mounjaro: Dave Knapp?
On The Pen With Man On The Mounjaro: Dave Knapp is created and hosted by Dave Knapp.
URL copied to clipboard!